Alzheimer's disease and managed care: a convincing case for action
- PMID: 17458478
Alzheimer's disease and managed care: a convincing case for action
Erratum in
- Manag Care Interface. 2007 Jun;20(6):32
Abstract
More than 4 million Americans have Alzheimer's disease (AD), and practitioners diagnose at least 400,000 news cases eachyear. Although the disease accounts for $24.6 billion in direct costs annually, it also generaites an additional $36.5 billion in indirect costs, including those attributed to lost productivityand absenteeism of caregivers for persons with AD. The increasing prevalence of AD will affect health plans with Medicare Advantage plans, as well as Medicare itself. Managed care faces challenges, both now and in the future, to deal with the effects of the disease.
Similar articles
-
2008 Alzheimer's disease facts and figures.Alzheimers Dement. 2008 Mar;4(2):110-33. doi: 10.1016/j.jalz.2008.02.005. Alzheimers Dement. 2008. PMID: 18631956
-
Prevalence, costs, and treatment of Alzheimer's disease and related dementia: a managed care perspective.Am J Manag Care. 2001 Aug;7(8):809-18. Am J Manag Care. 2001. PMID: 11519239 Review.
-
2009 Alzheimer's disease facts and figures.Alzheimers Dement. 2009 May;5(3):234-70. doi: 10.1016/j.jalz.2009.03.001. Alzheimers Dement. 2009. PMID: 19426951
-
The cost of Alzheimer's disease in managed care: a cross-sectional study.Am J Manag Care. 1999 Jul;5(7):867-77. Am J Manag Care. 1999. PMID: 10557408
-
The pharmacoeconomics of Alzheimer's disease.Am J Manag Care. 2000 Dec;6(22 Suppl):S1139-44; discussion S1145-8. Am J Manag Care. 2000. PMID: 11142178 Review.